DGAP-CMS: CompuGroup Medical SE & Co. KGaA: Share Buy-Back Program - 9th Interim Announcement, concurrently Completion Announcement
2021. április 30., péntek, 07:53
Disclosure pursuant to Art. 5 para. 1 lit. b) and para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 para. 2 and para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 CompuGroup Medical SE & Co. KGaA: Share Buy-Back Program - 9th Interim Announcement, concurrently Completion Announcement In the period from April 28, 2021 until and including April 29, 2021, CompuGroup Medical SE & Co. KGaA has bought back an aggregate number of 5,983 shares in CompuGroup Medical SE & Co. KGaA within its share buy-back program which had been announced on February 25, 2021 pursuant to Art. 2 para. 1 Commission Delegated Regulation (EU) No 2016/1052 to start on February 26, 2021 and which has been increased and extended as per announcement on March 25, 2021. The aggregate number of shares bought back each day during the period from April 28, 2021 until and including April 29, 2021 as well as the daily volume-weighted average prices for such buy-backs are as follows:
The aggregate number of shares bought back within the share buy-back program in the period from February 26, 2021 until and including April 29, 2021 amounts to 1,000,000 shares. The maximum number of shares to be bought back under the share buy-back program has been reached on April 29, 2021 and the share buy-back program is therefore completed. The purchase price per share paid for the 500,000 shares bought up to the increase and extension of the share buy-back program amounted to an average of EUR 69.1251. The purchase price per share paid for the 500,000 shares bought back after the increase and extension of the share buy-back program announced on March 25, 2021 was on average EUR 73.3665. In total, the purchase price per share paid for the 1,000,000 shares repurchased on the stock exchange was EUR 71.2458. Detailed information about the transactions are published on the company"s website under www.cgm.com/sbb. The acquisitions of the shares in CompuGroup Medical SE & Co. KGaA were carried out by a credit institution assigned by CompuGroup Medical SE & Co. KGaA exclusively via the Frankfurt Stock Exchange (XETRA trading). Koblenz, April 30, 2021 CompuGroup Medical SE & Co. KGaA
|
Language: | English |
Company: | CompuGroup Medical SE & Co. KGaA |
Maria Trost 21 | |
56070 Koblenz | |
Germany | |
Internet: | www.cgm.com |
End of News | DGAP News Service |
1190924 30.04.2021
Közzétételek - archívum
-
» Laxxon Medical to Participate in the BIO CEO & Investor Conference
[2023.02.02. 20:15]
-
» PJSC Magnitogorsk Iron and Steel Works: MMK notifies on additional extension of consent solicitation process
[2022.06.30. 13:00]
-
» Evonik Industries and Laxxon Medical see future in 3D screen printed pharmaceuticals
[2022.03.08. 15:02]
-
» Evonik und Laxxon Medical sehen Zukunftsmarkt für 3D-Druck von Tabletten
[2022.03.08. 15:02]
-
» "Game Changing" Technology Enables QR Code Integration with 3D Screen Printing
[2022.02.16. 17:31]
-
» Laxxon Medical to Participate in the 24th Annual Needham Virtual Growth Conference
[2022.01.07. 16:40]
-
» EQS-News: Focus Financial Partners Announces the Launch of Beryllus Capital in a Leading-Edge Joint Venture with the Hinduja Group
[2021.03.22. 12:45]
-
» DGAP-Adhoc: TRATON SE: TRATON und Navistar einig über Fortsetzung der Gespräche
[2020.10.16. 18:43]
-
» DGAP-Adhoc: TRATON SE: TRATON and Navistar agreement in principle
[2020.10.16. 18:43]